Page last updated: 2024-10-29

ketamine and Collagen Diseases

ketamine has been researched along with Collagen Diseases in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Collagen Diseases: Historically, a heterogeneous group of acute and chronic diseases, including rheumatoid arthritis, systemic lupus erythematosus, progressive systemic sclerosis, dermatomyositis, etc. This classification was based on the notion that collagen was equivalent to connective tissue, but with the present recognition of the different types of collagen and the aggregates derived from them as distinct entities, the term collagen diseases now pertains exclusively to those inherited conditions in which the primary defect is at the gene level and affects collagen biosynthesis, post-translational modification, or extracellular processing directly. (From Cecil Textbook of Medicine, 19th ed, p1494)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Salik, I1
Kubal, K1
Barst, S1

Other Studies

1 other study available for ketamine and Collagen Diseases

ArticleYear
Anesthetic Implications of a Patient With Kniest Dysplasia and Mitochondrial Disease: A Case Report.
    A&A practice, 2019, Apr-15, Volume: 12, Issue:8

    Topics: Anesthesia; Anesthetics; Cataract Extraction; Child; Cleft Palate; Collagen Diseases; Dexmedetomidin

2019